Sio Capital Management, LLC Akero Therapeutics, Inc. Transaction History
Sio Capital Management, LLC
- $266 Million
- Q1 2025
A detailed history of Sio Capital Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Sio Capital Management, LLC holds 85,000 shares of AKRO stock, worth $4.65 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
85,000Holding current value
$4.65 Million% of portfolio
1.29%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
270Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$406 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$387 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$325 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$306 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$287 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.54B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...